Effects of Vinorelbine on Cisplatin Resistance Reversal in Human Lung Cancer A549/DDP Cells

  • Zhou, Yu-Ting (Department of Thoracic, Qilu Hospital of Shandong University) ;
  • Li, Kun (Affliated Hospital of Shandong Academy of Medical) ;
  • Tian, Hui (Department of Thoracic, Qilu Hospital of Shandong University)
  • Published : 2013.08.30


Multi-drug resistance (MDR) is an essential aspect of human lung cancer chemotherapy failure. Recent studies have shown that vinorelbine is involved in underlying processes in human tumors, reversing the MDR inseveral types of cancer cells. However, the roles and potential mechanism are not fully clear. In this study, we explored effects of vinorelbine in multi-drug resistance reversal of human lung cancer A549/DDP cells. We found that vinorelbine increased drug sensitivity to cisplatin and intracellular accumulation of rhodamine-123, while decreasing expression of P-glycoprotein (P-gp), multi-drug resistance-associated protein (MRP1) and glutathione-S-transferase ${\pi}$ (GST-${\pi}$) in A549/DDP cells. At the same time, we also established downregulation of p-Akt and decreased transcriptional activation of NF-${\kappa}B$ and twist after vinorelbine treatment. The results indicated that vinorelbine might be used as a potential therapeutic strategy in human lung cancer.


Vinorelbine;human lung cancer;multidrug resistance


  1. Lu HY, Wang XJ, Mao WM (2013).Targeted therapies in small cell lung cancer. Oncol Lett, 1, 3-11.
  2. Ren YQ, Han JQ, Cao JB, Li SX, Fan GR (2012). Association of MDR1 gene polymorphisms with susceptibility to hepatocellular carcinoma in the Chinese population. Asian Pac J Cancer Prev, 11, 5451-4.
  3. Shukuya T, Takahashi T, Harada H, et al (2012).Comparison of vinorelbine plus cisplatin and S-1 plus cisplatin in concurrent chemoradiotherapeutic regimens for unresectable stage III non-small cell lung cancer. Anticancer Res, 2, 675-80.
  4. Wang J, Zhang J, Zhang L, et al (2011). Expression of P-gp, MRP, LRP, GST-$\pi$ and Topo IIa and intrinsic resistance in human lung cancer cell lines. Oncology Reports, 5, 1081-9.
  5. Wang L, Meng Q, Wang C, et al (2013). Dioscin Restores the Activity of the Anticancer Agent Adriamycin in Multidrug-Resistant Human Leukemia K562/Adriamycin Cells by Down-Regulating MDR1 via a Mechanism Involving NF-${\kappa}B$ Signaling Inhibition. J Nat Prod, 5, 909-14.
  6. Wang R, Liu C, Xia L, et al (2012). Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1. Clin Cancer Res, 24, 6690-701.
  7. Al Saleh S, Sharaf LH, Luqmani YA (2011). Signalling pathways involved in endocrine resistance in breast cancer and associations with epithelial to mesenchymal transition (Review). Int J Oncol, 5, 1197-217.
  8. Das S, Samant RS, Shevde LA (2013). Nonclassical activation of hedgehog signaling enhances multidrug resistance and makes cancer cells refractory to smoothened-targeting hedgehog inhibition. J Biol Chem, 17, 11824-33.

Cited by

  1. Anticancer Effects of Thymoquinone, Caffeic Acid Phenethyl Ester and Resveratrol on A549 Non-small Cell Lung Cancer Cells Exposed to Benzo(a)pyrene vol.14, pp.10, 2013,
  2. Effects of Ribosomal Protein L39-L on the Drug Resistance Mechanisms of Lung Cancer A549 Cells vol.15, pp.7, 2014,
  3. Effect and mechanism of peroxisome proliferator-activated receptor-γ on the drug resistance of the U-87 MG/CDDP human malignant glioma cell line vol.12, pp.2, 2015,
  4. Influence of the MACC1 Gene on Sensitivity to Chemotherapy in Human U251 Glioblastoma Cells vol.16, pp.1, 2015,